Vitamin D and the Skin: A Review for Dermatologists

Charpy, 1945, A propos du traitement du lupus tuberculeux; une question de priorité, Ann Dermatol Syphiligr., 5, 317 Deschasaux, 2016, What do people know and believe about vitamin D?, Nutrients., 8, 718, 10.3390/nu8110718 2010 Seamans, 2009, Existing and potentially novel functional markers of vitamin D status: A systematic review, Am J Clin Nutr., 89, 1997s, 10.3945/ajcn.2009.27230D Holick, 2011, Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline, J Clin Endocrinol Metab., 96, 1911, 10.1210/jc.2011-0385 Manson, 2016, Vitamin D deficiency — Is there really a pandemic?, N Engl J Med., 375, 1817, 10.1056/NEJMp1608005 Spiro, 2014, Vitamin D: An overview of vitamin D status and intake in Europe, Nutr Bull., 39, 322, 10.1111/nbu.12108 Pereira-Santos, 2016, Obesity and vitamin D deficiency: Is there an association?, Obes Rev., 17, 484, 10.1111/obr.12393 Mulligan, 2014, Cigarette smoke exposure is associated with vitamin D3 deficiencies in patients with chronic rhinosinusitis, J Allergy Clin Immunol., 134, 342, 10.1016/j.jaci.2014.01.039 Xiang, 2015, A systematic review of the influence of skin pigmentation on changes in the concentrations of vitamin D and 25-hydroxyvitamin D in serum following experimental UV irradiation, Photochem Photobiol Sci., 14, 2138, 10.1039/C5PP00168D Reyes-García, 2015, Update of recommendations for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions, Endocrinol Nutr., 62, e47, 10.1016/j.endonu.2015.01.011 Whittier, 2016, Glucocorticoid-induced osteoporosis, Rheum Dis Clin North Am., 42, 177, 10.1016/j.rdc.2015.08.005 Bikle, 2016, Extraskeletal actions of vitamin D, Ann N Y Acad., 1376, 29, 10.1111/nyas.13219 Kechichian, 2018, Vitamin D and the skin: An update for dermatologists, Am J Clin Dermatol., 19, 223, 10.1007/s40257-017-0323-8 Gilaberte, 2011, La vitamina D: evidencias y controversias, Actas Dermosifiliogr., 102, 572, 10.1016/j.ad.2011.03.015 Song, 2013, Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies, Diabetes Care., 36, 1422, 10.2337/dc12-0962 Inomata, 1986, Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus, Bone Miner., 1, 187 Kamycheva, 2007, Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity, J Endocrinol Invest., 30, 126, 10.1007/BF03347410 Zemel, 2000, Regulation of adiposity by dietary calcium, FASEB J., 14, 1132, 10.1096/fasebj.14.9.1132 Zittermann, 2009, Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers, Am J Clin Nutr., 89, 1321, 10.3945/ajcn.2008.27004 Pittas, 2004, Adipocytokines and insulin resistance, J Clin Endocrinol Metab., 89, 447, 10.1210/jc.2003-031005 Pfeifer, 2001, Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women, J Clin Endocrinol Metab., 86, 1633 Forman, 2013, Effect of vitamin D supplementation on blood pressure in blacks, Hypertension., 61, 779, 10.1161/HYPERTENSIONAHA.111.00659 Khan, 2018, Nanomedical studies of the restoration of nitric oxide/peroxynitrite balance in dysfunctional endothelium by 1,25-dihydroxy vitamin D3 — clinical implications for cardiovascular diseases, Int J Nanomedicine., 13, 455, 10.2147/IJN.S152822 Krafka, 1936, A simple treatment for psoriasis, J Lab Clin Med., 21, 1147 Thacker, 1940, The treatment of psoriasis with various vitamin D preparations, Illinois Med J., 78, 352 Bergler-Czop, 2016, Serum vitamin D level — the effect on the clinical course of psoriasis, Postepy Dermatol Alergol., 33, 445, 10.5114/ada.2016.63883 Orgaz-Molina, 2012, Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control study, J Am Acad Dermatol., 67, 931, 10.1016/j.jaad.2012.01.040 Barrea, 2017, Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist, Rev Endocr Metab Disord., 18, 195, 10.1007/s11154-017-9411-6 Silverberg, 2017, Public health burden and epidemiology of atopic dermatitis, Dermatol Clin., 35, 283, 10.1016/j.det.2017.02.002 Bieber, 2008, Atopic dermatitis, N Engl J Med., 358, 1483, 10.1056/NEJMra074081 Leung, 2003, Atopic dermatitis, Lancet., 361, 151, 10.1016/S0140-6736(03)12193-9 Kim, 2016, Vitamin D status and efficacy of vitamin D supplementation in atopic dermatitis: A systematic review and meta-analysis, Nutrients., 8, 10.3390/nu8120789 Van der Schaft, 2016, Serum vitamin D status in adult patients with atopic dermatitis: Recommendations for daily practice, J Am Acad Dermatol., 75, 1257, 10.1016/j.jaad.2016.07.035 Hata, 2008, Administration of oral vitamin D induces cathelicidin production in atopic individuals, J Allergy Clin Immunol, 122, 829, 10.1016/j.jaci.2008.08.020 Peroni, 2011, Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children, Br J Dermatol., 164, 1078, 10.1111/j.1365-2133.2010.10147.x Udompataikul, 2015, The effects of oral vitamin D supplement on atopic dermatitis: A clinical trial with Staphylococcus aureus colonization determination, J Med Assoc Thai., 98, s23 Haeck, 2009, Low bone mineral density in adult patients with moderate to severe atopic dermatitis, Br J Dermatol., 161, 1248, 10.1111/j.1365-2133.2009.09327.x Sethuraman, 2016, Vitamin D: A new promising therapy for congenital ichthyosis, Pediatrics., 137, 10.1542/peds.2015-1313 Lucker, 1994, Effect of topical calcipotriol on congenital ichthyoses, Br J Dermatol., 131, 546, 10.1111/j.1365-2133.1994.tb08558.x Okano, 2001, Assessment of the clinical effect of topical tacalcitol on ichthyoses with retentive hyperkeratosis, Dermatology., 202, 116, 10.1159/000051609 Neema, 2015, Vitamin D deficiency after oral retinoid therapy for ichthyosis, Pediatr Dermatol., 32, e151, 10.1111/pde.12614 Maynard, 1938, Vitamin D in acne: A comparison with X-ray treatment, Cal West Med., 49, 127 Lim, 2016, Comparison of vitamin D levels in patients with and without acne: A case-control study combined with a randomized controlled trial, PloS One., 11, e0161162, 10.1371/journal.pone.0161162 Lee, 2013, Expression of inflammatory biomarkers from cultured sebocytes was influenced by treatment with vitamin D, Indian J Dermatol., 58, 327, 10.4103/0019-5154.113959 Agak, 2014, Propionibacterium acnes induces an Il-17 response in acne vulgaris that is regulated by vitamin A and vitamin D, J Invest Dermatol., 134, 366, 10.1038/jid.2013.334 Zouboulis, 2017, Effects of extracellular calcium and 1,25 dihydroxyvitamin D3 on sebaceous gland cells in vitro and in vivo, Acta Derm Venereol., 97, 313, 10.2340/00015555-2525 El-Hamd, 2018, Vitamin D levels in acne vulgaris patients treated with oral isotretinoin, J Cosmet Dermatol. Kelly, 2014, Vitamin D status in hidradenitis suppurativa, Br J Dermatol., 170, 1379, 10.1111/bjd.12900 Karagiannidis, 2016, Hidradenitis suppurativa/Acne inversa: An endocrine skin disorder?, Rev Endocr Metab Disord., 17, 335, 10.1007/s11154-016-9366-z Guillet, 2015, Verneuil's disease, innate immunity and vitamin D: A pilot study, J Eur Acad Dermatol Venereol., 29, 1347, 10.1111/jdv.12857 Karagün, 2016, The role of serum vitamin D levels in vitiligo, Postepy Dermatol Alergol., 33, 300, 10.5114/pdia.2016.59507 Upala, 2016, Low 25-hydroxyvitamin D levels are associated with vitiligo: A systematic review and meta-analysis, Photodermatol Photoimmunol Photomed., 32, 181, 10.1111/phpp.12241 Lotti, 2008, Targeted and combination treatment for vitiligo. Comparative evaluation of different current modalities in 458 subjects, Dermatol Ther., 21, s20, 10.1111/j.1529-8019.2008.00198.x Parsad, 1998, Combination of PUVAsol and topical calcipotriol in vitiligo, Dermatology., 197, 167, 10.1159/000017991 Khurrum, 2016, The relationship between the serum level of vitamin D and vitiligo: A controlled study on 300 subjects, J Cutan Med Surg., 20, 139, 10.1177/1203475415610071 Monticielo, 2012, Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus, Clin Rheumatol., 31, 1411, 10.1007/s10067-012-2021-5 Amital, 2010, Serum concentration of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D?, Ann Rheum Dis., 69, 1155, 10.1136/ard.2009.120329 Eloi, 2017, 25-hydroxyvitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients, PloS One., 12, e0170323, 10.1371/journal.pone.0170323 Karimzadeh, 2017, The effect of vitamin D supplementation in disease activity of systemic lupus erythematosus patients with vitamin D deficiency: A randomized clinical trial, J Res Med Sci., 27, 4 Dall’Ara, 2018, Vitamin D and systemic lupus erythematous: A review of immunological and clinical aspects, Clin Exp Rheumatol., 36, 153 Hassanalilou, 2017, Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation, Auto Immun Highlights., 9, 1 Schweintzger, 2016, Influence of the season on vitamin D levels and regulatory T cells in patients with polymorphic light eruption, Photochem Photobiol Sci., 15, 440, 10.1039/C5PP00398A Gruber-Wackernagel, 2012, Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311nm UVB photohardening, Photochem Photobiol Sci., 11, 1831, 10.1039/C2PP25188D Gruber-Wackernagel, 2011, Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D3 analogue in polymorphic light eruption, Br J Dermatol., 165, 152, 10.1111/j.1365-2133.2011.10333.x Bakry, 2016, Serum vitamin D in patients with alopecia areata, Indian Dermatol Online J., 7, 371, 10.4103/2229-5178.190504 Mahamid, 2014, Association between vitamin D levels and alopecia areata, Isr Med Assoc J., 16, 367 Aksu Cerman, 2014, Vitamin D deficiency in alopecia areata, Br J Dermatol., 170, 1299, 10.1111/bjd.12980 D’Ovidio, 2013, Reduced level of 25-hydroxyvitamin D in chronic/relapsing alopecia areata, Dermatoendocrinol., 5, 271, 10.4161/derm.24411 Thompson, 2016, Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women, Arch Dermatol Res., 308, 671, 10.1007/s00403-016-1687-y Thompson, 2017, The role of micronutrients in alopecia areata: A review, Am J Clin Dermatol., 18, 663, 10.1007/s40257-017-0285-x Kim, 2012, Successful treatment of alopecia areata with topical calcipotriol, Ann Dermatol., 24, 341, 10.5021/ad.2012.24.3.341 Narang, 2017, Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study, Dermatol Ther., 30, e12464, 10.1111/dth.12464 Lim, 2018, High serum vitamin D level correlates with better prognostic indicators in primary melanoma: A pilot study, Australas J Dermatol., 59, 182, 10.1111/ajd.12648 Slominski, 2017, Vitamin D signaling and melanoma: Role of vitamin D and its receptors in melanoma progression and management, Lab Invest., 97, 706, 10.1038/labinvest.2017.3 Ombra, 2017, Vitamin D status and risk for malignant cutaneous melanoma: Recent advances, Eur J Cancer Prev., 26, 532, 10.1097/CEJ.0000000000000334 Hernández-Ortiz, 2016, Niveles de 25-hidroxivitamina D en pacientes con melanoma y factores asociados con su insuficiencia, Actas Dermosifiliogr., 107, 758, 10.1016/j.ad.2016.06.002 Orlow, 2018, The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival, Pigment Cell Melanoma Res., 31, 287, 10.1111/pcmr.12653 Newton-Bishop, 2009, Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma, J Clin Oncol., 27, 5439, 10.1200/JCO.2009.22.1135 Newton-Bishop, 2015, 25-hydroxyvitamin D2/D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort, Int J Cancer., 136, 2890, 10.1002/ijc.29334 Luo, 2017, No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival, PLoS One., 12, e0174234, 10.1371/journal.pone.0174234 Paolino, 2017, Vitamin D and melanoma: State of the art and possible therapeutic uses, G Ital Dermatol Venerol. Tang, 2012, Vitamin D in cutaneous carcinogenesis: Part II, J Am Acad Dermatol., 67, 817.e1, 10.1016/j.jaad.2012.05.044 Reddy, 2013, Vitamin D level and basal cell carcinoma, squamous cell carcinoma, and melanoma risk, J Invest Dermatol., 133, 589, 10.1038/jid.2012.427 Eide, 2011, Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort, Arch Dermatol., 147, 1379, 10.1001/archdermatol.2011.231 Albert, 2014, Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas, Adv Exp Med Biol., 810, 329 Burns, 2017, Association of vitamin D receptor polymorphisms with the risk of nonmelanoma skin cancer in adults, JAMA Dermatol., 153, 983, 10.1001/jamadermatol.2017.1976 Park, 2016, Vitamin D intake and risk of skin cancer in US women and men, PloS One., 11, e0160308, 10.1371/journal.pone.0160308 Roux, 2017, Imminent fracture risk, Osteoporos Int., 28, 1765, 10.1007/s00198-017-3976-5 Priemel, 2010, Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients, J Bone Miner Res., 25, 305, 10.1359/jbmr.090728 Bischoff-Ferrari, 2005, Positive association between serum 25-hydroxyvitamin D level and bone density in osteoarthritis, Arthritis Rheum., 53, 821, 10.1002/art.21601 Reid, 2014, Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis, Lancet., 383, 146, 10.1016/S0140-6736(13)61647-5 Bischoff-Ferrari, 2012, A pooled analysis of vitamin D dose requirements for fracture prevention, N Engl J Med., 367, 40, 10.1056/NEJMoa1109617 Peris, 2012, 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis, Bone., 51, 54, 10.1016/j.bone.2012.03.026 Adami, 2009, Vitamin D status and response to treatment in post-menopausal osteoporosis, Osteoporos Int., 20, 239, 10.1007/s00198-008-0650-y